Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Anticancer Research
|
July 15, 2009
Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status
Milos Pesek, Lucie Benesova, Barbora Belsanova, et al.
Anticancer Research
|
September 10, 2014
The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected]
Ondrej Fiala, Milos Pesek, Jindrich Finek, et al.
Pathology Oncology Research : POR
|
October 27, 2018
Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer
Lucie Benesova, Tereza Halkova, Bohus Bunganic, et al.
Anticancer Research
|
June 13, 2014
Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib
Ondrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research
|
December 27, 2011
Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease
Milos Pesek, Marta Kopeckova, Lucie Benesova, et al.
Anticancer Research
|
March 16, 2016
The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy
Martin Svaton, Ondrej Fiala, Milos Pesek, et al.
Anticancer Research
|
May 16, 2009
Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer
Cyril Salek, Petra Minarikova, Lucie Benesova, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 23, 2015
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation
Ondrej Fiala, Milos Pesek, Jindrich Finek, et al.
Electrophoresis
|
October 23, 2010
A novel high-resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA
Marek Minarik, Marcus Gassman, Barbora Belsanova, et al.
Genetic Testing and Molecular Biomarkers
|
August 4, 2009
Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy
Karol Curila, Lucie Benesova, Martin Penicka, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Anticancer Research
|
July 15, 2009
Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status
Milos Pesek, Lucie Benesova, Barbora Belsanova, et al.
Anticancer Research
|
September 10, 2014
The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected]
Ondrej Fiala, Milos Pesek, Jindrich Finek, et al.
Pathology Oncology Research : POR
|
October 27, 2018
Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer
Lucie Benesova, Tereza Halkova, Bohus Bunganic, et al.
Anticancer Research
|
June 13, 2014
Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib
Ondrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research
|
December 27, 2011
Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease
Milos Pesek, Marta Kopeckova, Lucie Benesova, et al.
Anticancer Research
|
March 16, 2016
The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy
Martin Svaton, Ondrej Fiala, Milos Pesek, et al.
Anticancer Research
|
May 16, 2009
Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer
Cyril Salek, Petra Minarikova, Lucie Benesova, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 23, 2015
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation
Ondrej Fiala, Milos Pesek, Jindrich Finek, et al.
Electrophoresis
|
October 23, 2010
A novel high-resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA
Marek Minarik, Marcus Gassman, Barbora Belsanova, et al.
Genetic Testing and Molecular Biomarkers
|
August 4, 2009
Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy
Karol Curila, Lucie Benesova, Martin Penicka, et al.
Page
of 6